INNT
TOTAL INVALIDATION PROCESSED BY THE IB
06/06/2025
Back to search
Official data from USPTO
TESSA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/07/2025
Trademark type
Combined
Nice classes
44
Filing date
07/08/2016
Registration date
12/19/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/05/2024
Last transaction
06/07/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
24
Owner location
SG
Examiner
SPILS, CAROL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Tessa Therapeutics Pte. Ltd.
Representatives
John C. Stringham Workman Nydegger
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services in the field of cancer treatments; medical assistance in the field of cancer treatments; cancer immunotherapy services; health care services for treating cancer not including cosmetic or plastic surgery for breast enlargement; health care not including cosmetic or plastic surgery for breast enlargement
Publications
History of USPTO decisions and trademark events.
28 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/22/2025
INPC
INVALIDATION PROCESSED
05/22/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/05/2025
C71T
CANCELLED SECTION 71
07/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/19/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/20/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/11/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/29/2018
FIMP
FINAL DISPOSITION PROCESSED
03/28/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/19/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2017
PUBO
PUBLISHED FOR OPPOSITION
10/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2017
RFNT
REFUSAL PROCESSED BY IB
03/18/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/01/2017
RFRR
REFUSAL PROCESSED BY MPU
03/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/28/2017
CNRT
NON-FINAL ACTION WRITTEN
02/27/2017
MAFR
APPLICATION FILING RECEIPT MAILED
02/22/2017
DOCK
ASSIGNED TO EXAMINER
02/18/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/16/2017
Continuous trademark protection
Get notified about every new filing that threatens TESSA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.